Back to search

A proposed metabolic strategy for monitoring disease progression in Alzheimer's disease

Data up to Jan 2025

Published2009
Citations86
References26

Total Citations Per Year

Abstract

References (26)

“Mini-mental state”

1975 • 82,784 citations

Targeting bile-acid signalling for metabolic diseases

2008 • 1,237 citations

Chemometrics in Metabonomics

2006 • 1,224 citations

Core candidate neurochemical and imaging biomarkers of Alzheimer's disease

2007 • 524 citations

Evidence for a membrane defect in Alzheimer disease brain.

1992 • 514 citations

A top‐down systems biology view of microbiome‐mammalian metabolic interactions in a mouse model

2007 • 459 citations

Proteome-based plasma biomarkers for Alzheimer's disease

2006 • 454 citations

High Resolution “Ultra Performance” Liquid Chromatography Coupled to oa-TOF Mass Spectrometry as a Tool for Differential Metabolic Pathway Profiling in Functional Genomic Studies

2005 • 411 citations

Medial temporal lobe atrophy and memory dysfunction as predictors for dementia in subjects with mild cognitive impairment

1999 • 315 citations

Tauroursodeoxycholic acid, a bile acid, is neuroprotective in a transgenic animal model of Huntington's disease

2002 • 293 citations

Biomarkers of Alzheimer disease in plasma

2004 • 268 citations

Choline metabolism as a basis for the selective vulnerability of cholinergic neurons

1992 • 244 citations

Mild Cognitive Impairment: A Systematic Review

2007 • 233 citations

Oxysterols, cholesterol homeostasis, and Alzheimer disease

2007 • 176 citations

Glycerophosphocholine is elevated in cerebrospinal fluid of Alzheimer patients

2004 • 152 citations

High-Resolution Serum Proteomic Profiling of Alzheimer Disease Samples Reveals Disease-Specific, Carrier-Protein–Bound Mass Signatures

2005 • 141 citations

Evaluation of a protocol for metabolic profiling studies on human blood plasma by combined ultra-performance liquid chromatography/mass spectrometry: From extraction to data analysis

2007 • 140 citations

Free choline and choline metabolites in rat brain and body fluids: sensitive determination and implications for choline supply to the brain

1993 • 114 citations

Heart fatty acid binding protein as a potential diagnostic marker for neurodegenerative diseases

2004 • 84 citations

Proteome-based identification of plasma proteins associated with hippocampal metabolism in early Alzheimer’s disease

2008 • 83 citations

Biomarkers for disease modification trials--the innovative medicines initiative and AddNeuroMed.

2007 • 75 citations

Discovery and development of biomarkers of neurological disease

2005 • 73 citations

Tauroursodeoxycholic acid modulates p53‐mediated apoptosis in Alzheimer's disease mutant neuroblastoma cells

2006 • 68 citations

Biomarkers for Alzheimer’s disease

2007 • 33 citations

Diagnosing Alzheimer's disease—non‐clinicians and computerised algorithms together are as accurate as the best clinical practice

2007 • 28 citations

Evaluation of Factors of Importance for Clinical Dementia Diagnosis

2005 • 4 citations

Cited By (0)

No citing papers found in database

A proposed metabolic strategy for monitoring disease progression in Alzheimer's disease (2009) – Electrophoresis | Metascience Observatory Explorer